Related Experiment Video
Updated: Jun 25, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Chronic daily headache with medication overuse: predictors of outcome 1 year after withdrawal therapy
M G Bøe1, R Salvesen, A Mygland
1Department of Neurology, Sørlandet Hospital, Kristiansand, Norway. magne.geir.boe@sshf.no
Insights
Withdrawal therapy for probable medication overuse headache shows variable success. Poor outcomes are linked to codeine use, poor sleep quality, and high bodily pain, suggesting sleep issues warrant attention.
Area of Science:
- Neurology
- Pain Medicine
- Pharmacology
Background:
- Medication overuse headache (MOH) is a common condition.
- Withdrawal therapy is a primary treatment for MOH.
- Predicting treatment success is crucial for patient management.
Purpose of the Study:
- To prospectively evaluate withdrawal therapy outcomes in 80 patients with probable MOH.
- To identify baseline patient characteristics predicting treatment success after one year.
Main Methods:
- Patients were classified based on headache day improvement after withdrawal.
- Outcome was measured as percentage improvement in headache days from baseline.
- The SF-36 quality of life tool assessed pain and sleep quality.
Main Results:
- 36% of patients achieved at least 50% improvement in headache days.
- 64% had less than 50% improvement; 30% of these had less than 10% improvement.
- Predictors of poor outcome included codeine-containing drug use, low sleep quality, and high bodily pain (SF-36).
Conclusions:
- Withdrawal therapy for MOH yields varied results.
- Codeine use, poor sleep, and high pain are associated with poorer outcomes.
- Addressing sleep problems may improve withdrawal therapy success in MOH patients.
Background And Purpose:
We examined prospectively the results of withdrawal therapy in 80 patients with probable medication overuse headache. The aim was to identify baseline patient characteristics that might predict outcome after 1 year (end of study).
Methods:
We classified patients according to results of withdrawal therapy measured as the improvement of headache days (HD) from baseline to end of study.
Results:
Thirty-six per cent (29/80) had at least 50% improvement. Sixty-four per cent (51/80) had <50% improvement, and among these, 30% (24/80) had <10% improvement. The following baseline characteristics were associated with poor outcome of withdrawal therapy: use of codeine-containing drugs, low self-reported sleep quality, and high self-reported bodily pain as measured by the quality of life tool SF-36.
Conclusion:
Before suggesting withdrawal therapy, one should probably pay more close attention to sleep problems.
Related Concept Videos
Desensitization and Tachyphylaxis
Several...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Drug Dependence
Psychosis: Goals of Pharmacotherapy
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Analgesia and Pain Management

